264 DEFICIENCY IN PLACENTAL GROWTH FACTOR CAUSES A DECREASED PORTO-SYSTEMIC COLLATERAL VESSEL FORMATION IN PORTAL HYPERTENSIVE MICE

Christophe Van Steenkiste; Anja Geerts; Eline Vanheule; Hans Van Vlierberghe; Filip De Vos; Peter Carmeliet; Martine De Vos; Isabelle Colle

doi:10.1016/s0168-8278(08)60266-4

Related publications

Article2008

Deficiency in placental growth factor causes a decreased portosystemic collateral vessel information in portal hypertensive mice

Christophe Van Steenkiste, Anja Geerts, Eline Vanheule, Hans Van Vlierberghe, Filip De Vos, Peter Carmeliet, Martine De Vos, Isabelle Colle

Article2006

Placental growth factor plays a role in the mesenteric neo-angiogenesis of portal hypertensive mice

Anja Geerts, Eline Vanheule, Peter Carmeliet, Hans Van Vlierberghe, Luc Leybaert, Martine De Vos, Isabelle Colle

Article2009

Deficiency in Placental Growth Factor improves inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic mice

Christophe Van Steenkiste, Anja Geerts, Jordi Ribera, Sònia Tugues, Manuel Morales‐Ruiz, Jean Marie Stassen, Peter Carmeliet, Ekhart Verdegem, Louis Libbrecht, Martine De Vos, Hans Van Vlierberghe, Isabelle Colle

Article2008

The use of antibodies against the placental growth factor as a new therapeutic target in the pathophysiology of portal hypertensive mice

Christophe Van Steenkiste, Anja Geerts, Eline Vanheule, Hans Van Vlierberghe, Filip De Vos, Peter Carmeliet, Martine De Vos, Jean–Marie Stassen, Désiré Collen, Isabelle Colle

Article2008

The use of antibodies against the placental growth factor in the prophylactic setting in the pathophysiology of portal hypertensive mice

Christophe Van Steenkiste, Anja Geerts, Eline Vanheule, Hans Van Vlierberghe, Filip De Vos, Peter Carmeliet, Martine De Vos, Jean–Marie Stassen, Désiré Collen, Isabelle Colle

264 DEFICIENCY IN PLACENTAL GROWTH FACTOR CAUSES A DECREASED PORTO-SYSTEMIC COLLATERAL VESSEL FORMATION IN PORTAL HYPERTENSIVE MICE

Discussion(0)

Related publications

Deficiency in placental growth factor causes a decreased portosystemic collateral vessel information in portal hypertensive mice

Placental growth factor plays a role in the mesenteric neo-angiogenesis of portal hypertensive mice

Deficiency in Placental Growth Factor improves inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic mice

The use of antibodies against the placental growth factor as a new therapeutic target in the pathophysiology of portal hypertensive mice

The use of antibodies against the placental growth factor in the prophylactic setting in the pathophysiology of portal hypertensive mice